INVESTIGATIVE CRITIQUE OF THE PAPER ENTITLED " HYDROXYCHLOROQUINE AND AZITHROMYCIN AS A TREATMENT OF COVID-19: RESULTS OF AN OPEN-LABEL NON-RANDOMIZED CLINICAL TRIAL", AUTHORED BY GAUTRET, P., LAGIER, J.-C., PAROLA, P., HOANG, V.T., MEDDEB, L., MAILHE, M., DOUDIER, B., 	COURJON, J., GIORDANENGO, V., VIEIRA, V.E., TISSOT, H., HONERE, S., LA SCOLA, B., ROLAIN, 	J.-M., BROUQUI, P. AND RAOULT, D., AND PUBLISHED IN INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS [(INT. J. ANTIMICROB. AGENTS (2020), … | Zendy

H.Y. Lim Tung | Zendy

Open Access

INVESTIGATIVE CRITIQUE OF THE PAPER ENTITLED " HYDROXYCHLOROQUINE AND AZITHROMYCIN AS A TREATMENT OF COVID-19: RESULTS OF AN OPEN-LABEL NON-RANDOMIZED CLINICAL TRIAL", AUTHORED BY GAUTRET, P., LAGIER, J.-C., PAROLA, P., HOANG, V.T., MEDDEB, L., MAILHE, M., DOUDIER, B., COURJON, J., GIORDANENGO, V., VIEIRA, V.E., TISSOT, H., HONERE, S., LA SCOLA, B., ROLAIN, J.-M., BROUQUI, P. AND RAOULT, D., AND PUBLISHED IN INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS [(INT. J. ANTIMICROB. AGENTS (2020), …

Author(s) -

H.Y. Lim Tung

Publication year - 2020

Publication title -

zenodo (cern european organization for nuclear research)

Language(s) - English

DOI - 10.5281/zenodo.4295553

Subject(s) - azithromycin , hydroxychloroquine , covid-19 , medicine , randomized controlled trial , traditional medicine , virology , outbreak , biology , microbiology and biotechnology , antibiotics , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research